Ordinary Rebalance | Solactive China MedTech Index | Effective Date 15th January 2024
In the ordinary rebalance, the following composition will be implemented effective open 15.01.2024:
| AIER EYE HOSPITAL GROUP CO-A |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
| ANDON HEALTH CO LTD-A |
| APT MEDICAL INC |
| AUTOBIO DIAGNOSTICS CO LTD-A |
| BEIJING STRONG BIOTECHNOLO-A |
| BGI GENOMICS CO LTD-A |
| DOUBLE MEDICAL TECHNOLOGY-A |
| EYEBRIGHT MEDICAL TECHNOLO-A |
| GENSCRIPT BIOTECH CORP |
| IMEIK TECHNOLOGY DEVELOPMENT CO LTD-A |
| INTCO MEDICAL TECHNOLOGY C-A |
| IRAY TECHNOLOGY CO LTD-A |
| JAFRON BIOMEDICAL CO LTD-A |
| JD HEALTH INTERNATIONAL INC |
| JIANGSU YUYUE MEDICAL EQU-A |
| LEPU MEDICAL TECHNOLOGY-A |
| MEINIAN ONEHEALTH HEALTHCA-A |
| MICRO-TECH NANJING CO LTD-A |
| MICROPORT SCIENTIFIC CORP |
| OVCTEK CHINA INC-A |
| PING AN HEALTHCARE AND TECHNOL |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD |
| SHANGHAI UNITED IMAGING HEALTHCARE CO LTD |
| SHENZHEN MINDARY BIO-MEDICAL ELECTRONICS CO LTD |
| SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO LTD |
| SINOCARE INC – A |
| SONOSCAPE MEDICAL CORP-A |
| WINNER MEDICAL CO LTD-A |
| WINNING HEALTH TECHNOLOGY-A |